Margo Heath-Chiozzi
SVP of Regulatory Affairs, Celldex Therapeutics.
Companies
- Celldex TherapeuticsSVP of Regulatory Affairs Oct 3, 2017 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Celldex Therapeutics CLDX13,383 shares2$395.5K at $29.55Jun 3, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 3, 2024Sold 58,369 shares at $33.65 of Celldex Therapeutics2
- Jun 3, 2024Exercised options 58,369 shares at $10.38 of Celldex Therapeutics2
- Jun 3, 2024Exercised options 6,289 shares at $9.02 of Celldex Therapeutics2
- May 30, 2024Sold 38,719 shares at $34.07 of Celldex Therapeutics3
- May 30, 2024Exercised options 2,608 shares at $10.38 of Celldex Therapeutics3
- May 30, 2024Exercised options 2,043 shares at $9.02 of Celldex Therapeutics3
- May 30, 2024Exercised options 29,068 shares at $2.78 of Celldex Therapeutics3
- Dec 8, 2021Sold 600 shares at $40.00 of Celldex Therapeutics4
- Dec 8, 2021Exercised options 600 shares at $2.78 of Celldex Therapeutics4
- Nov 1, 2021Sold 600 shares at $41.71 of Celldex Therapeutics5
- Nov 1, 2021Exercised options 600 shares at $2.78 of Celldex Therapeutics5
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Jun 3, 2024
- 4SEC EDGARForm 4 filed Dec 10, 2021
- 5SEC EDGARForm 4 filed Nov 3, 2021